It has been reported that an increased expression of osteopontin seems to be linked to prostate cancer development and progression, such as PIN and prostate cancer, and metastatic cancer cells in several transgenic mouse models of prostate cancer, including cRXRα−/− and cPten−/− mice [45]. The gene discussed is SPP1; the disease is prostate intraepithelial neoplasia.